Metraipolis › archive › dc_c05023a42ba3

Effect of Renal Impairment on the Pharmacokinetics and Safety of Doxecitine and Doxribtimine: A Single-Dose Phase 1 Study — Europe PMC PMID:41689170

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41689170
DOI
10.1002/cpdd.70036
License (as archived)
solo-consultazione
Archived
2026-11-06T08:44:10.114Z
SHA-256 of the archived text
200d6c2a4b1062a977e7b50e208400deb9a31429ef416f61a74fb4453261d744
Stable URL of this page
https://metraipolis.com/documento/dc_c05023a42ba3

How to cite

Effect of Renal Impairment on the Pharmacokinetics and Safety of Doxecitine and Doxribtimine: A Single-Dose Phase 1 Study — Europe PMC PMID:41689170 — Europe PMC (en), https://europepmc.org/article/MED/41689170 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c05023a42ba3 (Metraipolis archive dc_c05023a42ba3, sha256 200d6c2a4b1062a977e7b50e208400deb9a31429ef416f61a74fb4453261d744)
BibTeX
@misc{dcc05023a42ba3,
  title = {Effect of Renal Impairment on the Pharmacokinetics and Safety of Doxecitine and Doxribtimine: A Single-Dose Phase 1 Study — Europe PMC PMID:41689170},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41689170},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c05023a42ba3; sha256 200d6c2a4b1062a977e7b50e208400deb9a31429ef416f61a74fb4453261d744},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41689170. Agents can read the archived copy with the MCP tool read_document.